IT202200010277A1 - “Nutraceutical or pharmaceutical composition for male infertility” - Google Patents

“Nutraceutical or pharmaceutical composition for male infertility” Download PDF

Info

Publication number
IT202200010277A1
IT202200010277A1 IT102022000010277A IT202200010277A IT202200010277A1 IT 202200010277 A1 IT202200010277 A1 IT 202200010277A1 IT 102022000010277 A IT102022000010277 A IT 102022000010277A IT 202200010277 A IT202200010277 A IT 202200010277A IT 202200010277 A1 IT202200010277 A1 IT 202200010277A1
Authority
IT
Italy
Prior art keywords
nutraceutical
pharmaceutical composition
male infertility
infertility
male
Prior art date
Application number
IT102022000010277A
Other languages
Italian (it)
Inventor
Maio Umberto Di
Original Assignee
Neilos S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neilos S R L filed Critical Neilos S R L
Priority to IT102022000010277A priority Critical patent/IT202200010277A1/en
Publication of IT202200010277A1 publication Critical patent/IT202200010277A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
IT102022000010277A 2022-05-18 2022-05-18 “Nutraceutical or pharmaceutical composition for male infertility” IT202200010277A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IT102022000010277A IT202200010277A1 (en) 2022-05-18 2022-05-18 “Nutraceutical or pharmaceutical composition for male infertility”

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT102022000010277A IT202200010277A1 (en) 2022-05-18 2022-05-18 “Nutraceutical or pharmaceutical composition for male infertility”

Publications (1)

Publication Number Publication Date
IT202200010277A1 true IT202200010277A1 (en) 2023-11-18

Family

ID=83081026

Family Applications (1)

Application Number Title Priority Date Filing Date
IT102022000010277A IT202200010277A1 (en) 2022-05-18 2022-05-18 “Nutraceutical or pharmaceutical composition for male infertility”

Country Status (1)

Country Link
IT (1) IT202200010277A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103263018A (en) * 2013-04-27 2013-08-28 北京中国科学院老专家技术中心 Nitric oxide functional beverage and preparation method thereof
US20130295068A1 (en) * 2006-02-03 2013-11-07 Fapa Vital Anstalt Combination preparation for improving sperm quality
WO2019239268A1 (en) * 2018-06-15 2019-12-19 Angelo Chieregati Composition for the treatment of infertility
WO2021136784A1 (en) * 2019-12-30 2021-07-08 Laboratorio Reig Jofré, S.A. A composition for the treatment of male infertility
WO2021224153A1 (en) * 2020-05-04 2021-11-11 Parthenogen Sagl Combination of micronutrients to stimulate the endogenous production of hydrogen sulfide (h2s)

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130295068A1 (en) * 2006-02-03 2013-11-07 Fapa Vital Anstalt Combination preparation for improving sperm quality
CN103263018A (en) * 2013-04-27 2013-08-28 北京中国科学院老专家技术中心 Nitric oxide functional beverage and preparation method thereof
WO2019239268A1 (en) * 2018-06-15 2019-12-19 Angelo Chieregati Composition for the treatment of infertility
WO2021136784A1 (en) * 2019-12-30 2021-07-08 Laboratorio Reig Jofré, S.A. A composition for the treatment of male infertility
WO2021224153A1 (en) * 2020-05-04 2021-11-11 Parthenogen Sagl Combination of micronutrients to stimulate the endogenous production of hydrogen sulfide (h2s)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Week 201377, Derwent World Patents Index; AN 2013-V29330, XP002807750 *

Similar Documents

Publication Publication Date Title
CO2021003036A2 (en) Fused Ring Compounds
CO2021005987A2 (en) Fused ring compounds
BR112017012377A2 (en) antibody-drug conjugates with cell-permeable bcl-x1 inhibitors
MX2020004932A (en) Compounds useful for inhibiting cdk7.
BRPI0520669A2 (en) pharmaceutical dosage that reduces the effect of food found for atorvastatin administration
CL2019001337A1 (en) Pharmaceutical formulations.
GB202019241D0 (en) Pharmaceutical composition
BR112021017350A2 (en) Combination of antibody-pyrrolobenzodiazepine derivative conjugate and parp inhibitor
BR112022008365A2 (en) CD73 INHIBITORS
UY37941A (en) DERIVATIVES OF BENCIMIDAZOL AND ITS USES
IT202200010592A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010583A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010277A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010280A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200010274A1 (en) “Nutraceutical or pharmaceutical composition for male infertility”
IT202200004958A1 (en) “Nutraceutical or pharmaceutical composition for renal well-being”
IT202200008867A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008879A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008534A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
IT202200008537A1 (en) “Nutraceutical or pharmaceutical composition for cardiovascular health”
CR20220587A (en) PHARMACEUTICAL FORMULATIONS
CO2024005025A2 (en) Enzalutamide Oral Liquid Compositions
GB202313738D0 (en) Pharmaceutical compositions
UA46306S (en) 1.-2. SIGN FOR HEALTHCARE INSTITUTION
GB202108387D0 (en) Pharmaceutical composition